Yili Chuannig Biotechnology Co (SZSE:301301) COGS-to-Revenue : 0.66 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co COGS-to-Revenue?

Yili Chuannig Biotechnology Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥999 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥1,523 Mil.

Yili Chuannig Biotechnology Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.66.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Yili Chuannig Biotechnology Co's Gross Margin % for the three months ended in Mar. 2024 was 34.42%.

Yili Chuannig Biotechnology Co COGS-to-Revenue Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co COGS-to-Revenue Chart

Yili Chuannig Biotechnology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.79

0.78

0.75

0.68

Yili Chuannig Biotechnology Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial											0.74	0.69	0.67	0.64	0.66

Yili Chuannig Biotechnology Co COGS-to-Revenue Calculation

Yili Chuannig Biotechnology Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3300.397	/	4823.335
	=	0.68

Yili Chuannig Biotechnology Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	998.935	/	1523.218
	=	0.66

Yili Chuannig Biotechnology Co (SZSE:301301) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Yili Chuannig Biotechnology Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	998.935 / 1523.218
	=	34.42 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Yili Chuannig Biotechnology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yili Chuannig Biotechnology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Yili Chuannig Biotechnology Co (SZSE:301301) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000

Website

http://www.klcnsw.com

Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co (SZSE:301301) Headlines

No Headlines